GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PEPTONIC medical AB (XSAT:PMED) » Definitions » Research & Development

PEPTONIC medical AB (XSAT:PMED) Research & Development : kr0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is PEPTONIC medical AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. PEPTONIC medical AB's Research & Development for the three months ended in Mar. 2024 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.00 Mil.

PEPTONIC medical AB Research & Development Historical Data

The historical data trend for PEPTONIC medical AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PEPTONIC medical AB Research & Development Chart

PEPTONIC medical AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PEPTONIC medical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PEPTONIC medical AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PEPTONIC medical AB  (XSAT:PMED) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PEPTONIC medical AB Research & Development Related Terms

Thank you for viewing the detailed overview of PEPTONIC medical AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

PEPTONIC medical AB (XSAT:PMED) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PEPTONIC medical AB (XSAT:PMED) » Definitions » Research & Development
Comparable Companies
XSAT:ODI OSTO:VIVE XSAT:DICOT OSTO:ERMA OSTO:NANEXA OSTO:NEWBRY OSTO:KLAR OSTO:RLS OSTO:EMPLI OSTO:GABA ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
28L:Germany
Address
Gustavslundsvägen 143, Bromma, SWE, SE-167 51
Website
https://www.peptonicmedical.se
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.

PEPTONIC medical AB (XSAT:PMED) Headlines

No Headlines